Form 4 for LH Labcorp
Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0001127602-24-028580 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-04 | 2024-12-02 | LH | EISENBERG GLENN A | EVP | M - OptEx | $212.21 | +11.7K | 43.0K | +37% | +$2.49M |
| D | 2024-12-04 | 2024-12-02 | LH | EISENBERG GLENN A | EVP | S - Sale+OE | $240.43 | -11.7K | 31.3K | -27% | -$2.82M |
| DM | 2024-12-04 | 2024-12-02 | LH | EISENBERG GLENN A | EVP | M - OptEx | $0.00 | -11.7K | 5,577 | -68% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-02 | M | A | 8,923 | $209.25 | 40,212 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-02 | S | D | 11,711 | $240.43 | 31,289 | D | — | — | (F1) The price of $240.4279 per share represents a weighted average of sales prices ranging from $240.015 to $240.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
| 3 | Common | Common Stock | 2024-12-02 | M | A | 2,788 | $221.67 | 43,000 | D | — | — | |
| 4 | Derivative | Non-qualified Stock Options | 2024-12-02 | M | D | 8,923 | $0.00 | 0 | D | $209.25 · 2022-02-02 to 2031-02-01 | 8,923 Common Stock | (F2) Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. (F3) Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea. (F4) The option vested in three equal annual installments beginning on the date reflected in this column. |
| 5 | Derivative | Non-qualified Stock Options | 2024-12-02 | M | D | 2,788 | $0.00 | 5,577 | D | $221.67 · 2024-02-07 to 2033-02-06 | 2,788 Common Stock | (F2) Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. (F3) Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea. (F5) The option vests in three equal annual installments beginning on the date reflected in this column. |